Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Santosh Kesari is a world-renowned neuro-oncologist and physician-scientist who leads a multi-faceted professional entity focused on translational neuro-oncology and precision medicine. Operating through his clinical practice, Asthra Health, and various biotech ventures he has founded or advised, Dr. Kesari specializes in developing and testing novel therapies for aggressive brain cancers like glioblastoma. His work spans a wide range of modalities, including small molecule inhibitors, monoclonal antibodies, and oncolytic viruses, often targeting cancer stem cells and the tumor microenvironment. He is a key figure at the Pacific Neuroscience Institute and the Saint John’s Cancer Institute, where he oversees numerous clinical trials and research programs. Dr. Kesari is a prolific inventor and entrepreneur, dedicated to integrating advanced diagnostics and personalized treatment strategies to improve outcomes for patients with complex neurological diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santosh Kesari.